What to know about Promacta (Eltrombopag) 

Promacta Copay Assistance comes in the form of various savings programs, which are often referred to as “Stelara copay cards.” These patient assistance programs can be very difficult for patients to find, enroll, and keep an active status. QuickRx will be there to guide you through it all.
Although these programs are free, many people are not aware they exist. That is where QuickRx comes in. We have a highly-skilled team dedicated to helping make prescription copays affordable for all who qualify by facilitating access to these programs.

You’ll never have to worry about jumping through hoops or wasting hours ever again. Each copay assistance program has their own set of rules and regulations. This is the part of the process that has proven to be frustrating for many people seeking copay assistance.

However, with QuickRx your experience will be anything but difficult. Our dedicated team will work to make the Stelara Copay Card process as seamless as possible for you. In fact, your part of the process involves just a few short, easy steps to find out if you qualify for copay assistance. Fill out the form above this section and someone from our amazing pharmacy team will contact you within 1-2 business days.

Step 1:
Get started using one of these options;

• You can call us at (917) 830-2525 or toll-free at (800)-496-6111.
• You can also fill out our Contact Form and someone will call you back within 1-2 business days.

Step 2:
Fill out some easy forms

Step 3:
Submit a few pieces of documentation to our team.

That’s it! From there, our team will help you find out if you qualify. If you meet the qualification guidelines, our team will ensure that your discounts are automatically applied for you at the pharmacy, coordinate pickup or home delivery of your medications, and they’ll even continue to monitor your case! With QuickRx you will have peace of mind knowing that you will never have any surprise lapse in copay assistance benefits.

Common Side Effects (Reported in ≥5% of Patients)

These are more likely but often manageable:

• Nausea

• Diarrhea

• Upper respiratory tract infection

• Fatigue

• Headache

• Cough

• Fever

• Back pain

• Pain in extremities

• Insomnia

• Muscle aches (myalgia)

• Oral pain or discomfort

Serious Side Effects (Require Immediate Medical Attention)

1. Liver Problems (Hepatotoxicity)

• Elevated liver enzymes (ALT, AST, bilirubin)

• Signs may include:

  • Yellowing of the skin or eyes (jaundice)

  • Dark urine

  • Fatigue

  • Upper right abdominal pain

Note: Liver function should be monitored regularly while on Promacta.

2. Blood Clots (Thromboembolism)

• Deep vein thrombosis (DVT)

• Pulmonary embolism (PE)

• Stroke

• Myocardial infarction (heart attack)

3. Cataracts

• Cloudy or blurred vision

• Eye discomfort

Note: Regular eye exams are recommended for long-term use.

4. Bone Marrow Reticulin Fibrosis

• Abnormal scarring in the bone marrow

• Can affect blood cell production

5. Worsening of Hematologic Malignancies

• Promacta is not approved for use in patients with blood cancers unless treating severe aplastic anemia.

• May stimulate cancer cell growth in some contexts.

Less Common or Rare Side Effects

• Mouth ulcers or dry mouth

• Rash or itching

• Dizziness

• Increased risk of infections (especially if white blood cells are also affected)

• Elevated creatinine or kidney abnormalities

• Heart palpitations

Monitoring and Lifestyle Considerations

Monitoring Recommendations

• Liver function tests (before and during treatment)

• Eye exams (especially if used long-term)

• Platelet counts (to avoid too high levels, which increase clot risk)

• Regular blood tests to monitor for changes in white/red blood cells

Lifestyle & Diet Notes

• Avoid calcium-rich foods or supplements within 2 hours of taking Promacta (calcium interferes with absorption).

• Maintain consistent follow-ups with your provider to adjust dosage as needed.

• Report any vision changes, signs of blood clots, or unusual bruising/bleeding immediately.